The company will not receive any of the proceeds from the sale of shares of common stock by the selling stockholders.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BOW:
- Bowhead Specialty management to meet with Citizens JMP
- Bowhead Specialty price target raised to $39 from $36 at Morgan Stanley
- Bowhead Specialty price target raised to $45 from $43 at Keefe Bruyette
- Bowhead Specialty Holdings Reports Strong Q1 2025 Results
- Bowhead Specialty Reports Strong Q1 2025 Financial Results